FindCure

Vanencell Biotech (Zhongshan) Co., Ltd. is a high-tech innovative biopharmaceutical company driven by exceptional independent research and development capabilities. It was co-founded by renowned industry expert Dr. Ning Xi and oncology clinical expert Professor Xueli Yuan, with a management team averaging over 20 years of R&D management experience both in China and abroad. The company focuses on areas with significant unmet needs, such as lung cancer and gastric cancer, specializing in the research and development of drugs targeting signaling pathways and immunotherapy. It is committed to developing "First-in-class" and "Best-in-class" drugs with breakthrough potential in the global market.